PAGUX | RBHTX | PAGUX / RBHTX | |
Total Expense Ratio | 0.70 | 1.46 | 48% |
Annual Report Gross Expense Ratio | 2.21 | 1.46 | 151% |
Fund Existence | 5 years | 18 years | - |
Gain YTD | 7.686 | 10.500 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.3M | 41.7B | 0% |
Annual Yield % from dividends | 4.40 | 0.42 | 1,039% |
Returns for 1 year | 9.16 | 9.50 | 96% |
Returns for 3 years | 40.44 | 39.03 | 104% |
Returns for 5 years | N/A | 39.30 | - |
Returns for 10 years | N/A | 70.58 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 21.59 | 0.53 | +2.52% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
IQSU | 49.68 | 0.18 | +0.37% |
NYLI Candriam U.S. Large Cap Equity ETF | |||
ETV | 13.74 | 0.04 | +0.29% |
Eaton Vance Tax-Managed Buy-Write Opportunities Fund | |||
TAIL | 11.81 | N/A | N/A |
Cambria Tail Risk ETF | |||
ELC | 20.26 | -0.12 | -0.59% |
Entergy Louisiana LLC |